CK Life Sciences Int'l (Holdings) Inc - Company Profile
Powered by 
All the data and insights you need on CK Life Sciences Int'l (Holdings) Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date CK Life Sciences Int'l (Holdings) Inc Strategy Report
- Understand CK Life Sciences Int'l (Holdings) Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on CK Life Sciences Int'l (Holdings) Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 27 Mar 2020 | CK Life Sciences Enters into Licensing Agreement with Agency for Science, Technology and Research (A*STAR) for Diagnostic Test Kit for COVID-19 | Partnership | - |
Agency for Science, Technology and Research
CK Life Sciences Development Limited
|
| 07 Sep 2018 | Regenal Investments to Acquire Remaining 27.7% Stake of Belvino Investments from LANV | Acquisition |
Regenal Investments Pty Limited
|
Belvino Investments Trust
Belvino Investments Pty Limited
|
| 07 Feb 2018 | WEX Pharmaceuticals Inc Enters Phase I Clinical Trial Agreement with Celerion Inc for Tetrodotoxin (GDCT0366564) | Contract Service Agreement |
WEX Pharmaceuticals Inc
|
Celerion Inc
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer